Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Thevis

Showing results (391-400 of 499) with videos related to

Pageof 50
Sort By:
Drug Testing and Analysis|April 1, 2010
Temporal indication of cannabis use by means of THC glucuronide determinationUte Mareck, Nadine Haenelt, Hans Geyer, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 10, 2014
Use of dried blood spots in doping control analysis of anabolic steroid estersLaura Tretzel, Andreas Thomas, Hans Geyer, et al.
Journal of Mass Spectrometry : JMS|August 5, 2024
A comprehensive gas chromatography electron ionization high resolution mass spectrometry study of a new steroidal selective androgen receptor modulator (SARM) compound S42Hui-Chung Wen, Tobias Wilczek, Jörg-M Neudörfl, et al.
International Journal of Legal Medicine|December 20, 2018
Phase I metabolic profiling of the synthetic cannabinoids THJ-018 and THJ-2201 in human urine in comparison to human liver microsome and cytochrome P450 isoenzyme incubationFranziska Gaunitz, Andreas Thomas, Mathias Fietzke, et al.
Drug Testing and Analysis|September 22, 2020
Elimination profiles of microdosed ostarine mimicking contaminated products ingestionKatja Walpurgis, Ana Rubio, Felicitas Wagener, et al.
European Journal of Clinical Pharmacology|August 30, 2014
Identification of black market products and potential doping agents in Germany 2010-2013Oliver Krug, Andreas Thomas, Katja Walpurgis, et al.
Rapid Communications in Mass Spectrometry : RCM|April 26, 2017
Mass spectrometric characterization of the selective androgen receptor modulator (SARM) YK-11 for doping control purposesMario Thevis, Thomas Piper, Josef Dib, et al.
Drug Testing and Analysis|September 28, 2010
Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controlsInes Möller, Annette Wintermeyer, Katja Bender, et al.
The Journal of Clinical Endocrinology and Metabolism|May 24, 2007
Evaluation of the biological activity of a growth hormone (GH) mutant (R77C) and its impact on GH responsiveness and statureVibor Petkovic, Amélie Besson, Mario Thevis, et al.
Drug Testing and Analysis|April 1, 2010
Comparison of the urinary protein patterns of athletes by 2D-gel electrophoresis and mass spectrometry-a pilot studyMaxie Kohler, Stefan Franz, Axel Regeniter, et al.
Pageof 50

Showing results (391-400 of 499) with videos related to

Sort By:
Pageof 50
Drug Testing and Analysis|April 1, 2010
Temporal indication of cannabis use by means of THC glucuronide determinationUte Mareck, Nadine Haenelt, Hans Geyer, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 10, 2014
Use of dried blood spots in doping control analysis of anabolic steroid estersLaura Tretzel, Andreas Thomas, Hans Geyer, et al.
Journal of Mass Spectrometry : JMS|August 5, 2024
A comprehensive gas chromatography electron ionization high resolution mass spectrometry study of a new steroidal selective androgen receptor modulator (SARM) compound S42Hui-Chung Wen, Tobias Wilczek, Jörg-M Neudörfl, et al.
International Journal of Legal Medicine|December 20, 2018
Phase I metabolic profiling of the synthetic cannabinoids THJ-018 and THJ-2201 in human urine in comparison to human liver microsome and cytochrome P450 isoenzyme incubationFranziska Gaunitz, Andreas Thomas, Mathias Fietzke, et al.
Drug Testing and Analysis|September 22, 2020
Elimination profiles of microdosed ostarine mimicking contaminated products ingestionKatja Walpurgis, Ana Rubio, Felicitas Wagener, et al.
European Journal of Clinical Pharmacology|August 30, 2014
Identification of black market products and potential doping agents in Germany 2010-2013Oliver Krug, Andreas Thomas, Katja Walpurgis, et al.
Rapid Communications in Mass Spectrometry : RCM|April 26, 2017
Mass spectrometric characterization of the selective androgen receptor modulator (SARM) YK-11 for doping control purposesMario Thevis, Thomas Piper, Josef Dib, et al.
Drug Testing and Analysis|September 28, 2010
Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controlsInes Möller, Annette Wintermeyer, Katja Bender, et al.
The Journal of Clinical Endocrinology and Metabolism|May 24, 2007
Evaluation of the biological activity of a growth hormone (GH) mutant (R77C) and its impact on GH responsiveness and statureVibor Petkovic, Amélie Besson, Mario Thevis, et al.
Drug Testing and Analysis|April 1, 2010
Comparison of the urinary protein patterns of athletes by 2D-gel electrophoresis and mass spectrometry-a pilot studyMaxie Kohler, Stefan Franz, Axel Regeniter, et al.
Pageof 50